great find - one would expect that it should be CX Bladder. Given that Kaiser have approved the commercial use, one would expect that the LCD must not be too far away. Could be a very good week for the share price.
LCD Meeting next week to consider "Prognostic and Predictive Molecular Classifier for Bladder Cancer", page-2
Add to My Watchlist
What is My Watchlist?